CDK4/6 Inhibition in Breast Cancer: Expert Perspectives on Integrating Guideline Updates and Recent Advances Into Practice
Experts discuss the latest clinical data and evolving role of CDK4/6 inhibitors in breast cancer across disease stages and explore emerging therapies, biomarker-driven approaches, and considerations for individualizing patient care in this certified on-demand webcast.
Myeloma Masterclass: Applying the Latest Guidelines for Evidence-Based, Equitable Care
Live satellite symposium with a panel of experts discussing current guidelines and latest clinical evidence for the management of patients with multiple myeloma including expert guidance to help inform treatment decisions and therapy sequencing.
CDK4/6 Inhibition in Breast Cancer: Expert Perspectives on Integrating Guideline Updates and Recent Advances Into Practice
Join us for this engaging session led by expert oncology faculty to learn the latest evidence and recommendations with CDK4/6 inhibitors for breast cancer. Insights on how to best mitigate CDK4/6 inhibitor–related adverse events will also be highlighted.
Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course
Join us for this dynamic, case-based, live symposium in collaboration with the NCCN to hear from an expert panel on current recommendations and emerging strategies for treating patients with CLL.
NCCN 2025 Annual Conference

The NCCN 2025 Annual Conference is designed to address timely and important educational needs of cancer care providers to improve and facilitate quality, effective, equitable and accessible cancer care so patients can live better lives.

NCCN 2025 Breast Cancer Congress with Updates from the 2024 San Antonio Breast Cancer Symposium
This program offers expert insights into current recommendations of care for patients with breast cancer and includes the latest clinical research updates to assist clinicians in formulating breast cancer management strategies.
An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates
The goal of this activity is to improve learners’ knowledge, competence, and confidence to integrate new and emerging therapies into practice to improve clinical outcomes in patients with chronic lymphocytic leukemia / small lymphocytic lymphoma.
Vital Questions for Treatment of Bladder Cancer: Expert Insights on Recent and Near-Future Changes
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with bladder cancer.
NCCN 2024 Annual Congress: Hematologic Malignancies™

This congress focuses on updates to the NCCN Guidelines®, new and emerging therapeutic agents, and practical management strategies to ensure optimal patient outcomes.

NCCN 2024 Annual Conference

The NCCN 2024 Annual Conference includes educational sessions that highlight significant updates and key issues for select NCCN Guidelines®, new and emerging therapies, controversies in oncology care, issues affecting oncology care, and strategies to address barriers to practice.

Pages

Subscribe to RSS - Live Course